Patent Issued for Medical device having capacitive coupling communication and energy harvesting (USPTO 11951280).

Becton Dickinson and Company has been issued a patent for a medical device that delivers drug therapy to individuals with diabetes. The device utilizes capacitive coupling communication and energy harvesting, and includes a microcontroller, pump mechanism, transceiver, and power supply system. It communicates with a host device through a personal area network and is powered by energy harvested from the user's body. This patent application highlights the use of proinsulin, a peptide hormone, in the device, which could potentially enhance healthcare and medical treatment options. [Extracted from the article]